Apixaban/rivaroxabanBleeding following off label use: 11 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1697卷 / 1期

关键词：

D O I：

10.1007/s40278-018-44621-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：65 / 65

相关论文

共 50 条

[31] SpironolactoneHyperkalaemia following off-label use: 3 case reports
Reactions Weekly, 2023, 1949 (1) : 385 - 385
[32] NabiloneSedation and xerostomia following off label use: 3 case reports
Reactions Weekly, 2017, 1667 (1) : 245 - 245
[33] ImiquimodLymphoedema following off-label use: 3 case reports
Reactions Weekly, 2018, 1711 (1) : 146 - 146
[34] MemantineVarious toxicities following an off label use: 4 case reports
Reactions Weekly, 2022, 1914 (1) : 282 - 282
[35] DexamethasonePsychosis and catatonia following off label use: 2 case reports
Reactions Weekly, 2022, 1927 (1) : 218 - 218
[36] TrametinibMild rash following off label use: 2 case reports
Reactions Weekly, 2017, 1664 (1) : 275 - 275
[37] DiazepamLack of efficacy following off label use: 12 case reports
Reactions Weekly, 2023, 1947 (1) : 154 - 154
[38] HydroxychloroquineHypoglycaemia following off-label use: 3 case reports
Reactions Weekly, 2020, 1822 (1) : 152 - 152
[39] SirolimusVarious toxicities following off label use: 7 case reports
Reactions Weekly, 2021, 1852 (1) : 390 - 390
[40] LetermovirCytopenia and pruritus following off label use: 2 case reports
Reactions Weekly, 2020, 1810 (1) : 128 - 128

← 1 2 3 4 5 →